BioTech/Drugs - N/A, N/A, CA
Spin out from Novartis Pharma.Developing a breakthrough small-molecule drug discovery technology harnessing mRNA modulation. Can identify new compounds for "so-called" non-drugable targets. Applicable to a broad range of disease areas.Strategy is to develop own products in the areas of oncology and inflammation whilst supporting revenues through drug-discovery collaborations with pharma companies.